Twenty patients with reflux oesophagitis causing a tight peptic oesophageal stricture entered a randomised double-blind crossover trial in which they received cimetidine, 1-6 g daily, and matching placebo each for six months. The gross endoscopic appearances of oesophagitis, though not the grades of histopathological changes, showed significant improvement during treatment with cimetidine. The need for dilatation of the strictures, however, was not reduced.
Introduction
Peptic oesophageal stricture is caused by reflux oesophagitis, whose severity is related to the acidity of the oesophageal contents.' Cimetidine, a potent inhibitor of the secretion of gastric acid and pepsin, reduces oesophageal acidity,2 relieves symptoms,3 4 and promotes healing of oesophagitis5 6 in patients with gastro-oesophageal reflux. To determine whether cimetidine is of benefit in the treatment of peptic oesophageal stricture we have studied its effect on symptoms, oesophagitis, and the need for dilatation in 20 patients with peptic oesophageal stricture resistant to conventional medical management of gastro-oesophageal reflux.
Patients and methods
Twenty patients, 10 men and 10 women aged 52-82 years (mean 70 years), entered the study. All had tight oesophageal strictures that, despite conventional medical measures to control reflux, had required at least two dilatations in the preceding six months or three in the preceding year. One patient suffered from systemic sclerosis, three had previously undergone vagotomy and pyloroplasty or a gastric resection for peptic ulcer, and one had undergone a Nissen fundoplication.
University Hospital, Nottingham NG7 2UH ROGER FERGUSON, MD, MRCP, senior medical registrar MICHAEL ATKINSON, MD, FRCP, consultant physician M W DRONFIELD, MB, MRCP, senior medical registrar Trial design-Cimetidine (400 mg four times daily) was compared with a placebo on a double-blind crossover basis, the preparations being given for six months each in random order. Symptoms, endoscopic and histopathological appearances, and the need for dilatation were recorded.
Symptoms-The occurrence of pain and the severity of dysphagia were recorded daily by the patients on a diary card, which they brought to the clinic on each monthly visit. Dysphagia was graded as the ability to swallow a normal diet (grade 0), a diet avoiding only certain solids such as steak or raw fruit (grade 1), a soft diet (grade 2), and a liquid diet (grade 3); those with grade 4 dysphagia had difficulty in taking even liquids in adequate amounts. All patients were weighed monthly in the clinic and throughout the trial took an antacid (Asilone Gel) as required for pain and were asked to sleep with the bed-head raised.
Endoscopy-The upper alimentary tract was examined using the Olympus GIFK fibreoptic endoscope at the beginning, after two months, and at the end of each six-month treatment period and whenever dysphagia became severe. The diameter of the stricture was measured and the degree of oesophagitis in the stricture assessed using a grading scale of 0 for normal mucosa, 1 for reddening, 2 for reddening and friability to touch, and 3 for ulceration.
Histopathology-Biopsy specimens from within the stricture were taken at endoscopy, and the degree of oesophagitis was graded histopathologically as normal (grade 0), mild inflammatory cell infiltration (grade 1), severe inflammatory cell infiltration (grade 2) , and ulceration (grade 3).
Dilatation-Dilatation of the stricture using the Eder Puestow metal olive dilators was done only when the stricture failed to admit the Olympus GIFK endoscope (external diameter 12 5 mm).
Results
Fourteen of the 20 patients completed the full trial: five died during the trial (of whom three had completed at least six months) and one was withdrawn after six months. In all, 16 treatments with cimetidine and 16 with placebo were completed.
Symptomatic response-The average number of days and nights per month during which pain occurred was 6-8 for the six months of placebo treatment and 4-1 for the six months of cimetidine treatment. This difference was not significant, but since the maximum score possible was 56 pain was apparently not a troublesome symptom. The grade of dysphagia at the end of each month averaged 0-45 for placebo and 0 76 for cimetidine. This difference was not significant.
Endoscopic appearances-On entering the trial all patients had intense oesophagitis with ulceration in the stricture (grade 3). To assess the change in the gross endoscopic appearances the grade of oesophagitis at the beginning was subtracted from that at the end of each treatment period (fig 1) . The degree of oesophagitis improved significantly during cimetidine treatment compared with placebo treatment (P < 0 05). During cimetidine treatment 10 of the 16 patients improved and one deteriorated, while during placebo treatment five improved and five deteriorated. (fig 2) . Some difficulty was encountered in this procedure, however, since at times gastric-type epithelium was obtained on biopsy within the stricture and it was difficult to compare this with previous biopsy specimens in which squamous epithelium had been present. for peptic ulcer, and the three patients in our study who had undergone vagotomy and drainage or gastric resection all needed frequent dilatations during both placebo and cimetidine treatment periods. Since our results show that cimetidine benefits oesophagitis, however, it seems reasonable to hope that a longer period of treatment might lessen the need for dilatation. In August 1978 he was admitted to Raigmore Hospital, Inverness, with a three-day history of tiredness, malaise, vomiting, diarrhoea, and a diminishing output of dark red urine. On admission his skin was dusky red, the conjunctivae icteric, the pulse rate 120/minute, and the blood pressure 130/80mm Hg. There was a normochromic anaemia-Hb 8-9 g/dl, which fell to 7-3 g/dl within the first day. The total white cell count was 19 4 x 109 (19 400/mm3) with 80 polymorphs. ESR was unreadable owing to intense haemolysis. Serum concentrations were: bilirubin 95 micromol/l (5 7 mg/ 100 ml); potassium 4-8 mmol/l (mEq/1); and creatinine 501 ,umol/l (5 5 mg/100 ml). Blood film showed heavy infestation of erythrocytes by an intracellular parasite.
The patient was transfused with concentrated red cells and his renal function closely monitored. The possible use of antibabesial drugs available in veterinary medicine was considered and a supply of diminazene (Berenil) arranged. In the interim intensive antimalarial therapy, initially with quinine intravenously followed by chloroquine intravenously and pyrimet2a-mine, 50 mg orally, was started. He appeared to improve and Me was an appreciable fall in the degree of parasitaemia. Nevertheless, renal function progressively deteriorated and he was transferred to Aberdeen for haemodialysis. By then his blood urea concentration was 64 mmol/l (384 mg/100 ml). Two haemodialyses were successfully completed but cardiac embarrassment developed owing to a pericardial effusion and, although 500 ml of blood-stained fluid was aspirated, his condition rapidly deteriorated and he died. Death was attributable to cardiac tamponade; at necropsy, the pericardial cavity contained blood clot and serosanguinous fluid. Uraemic pneumonitis and pleurisy were present. There was a para-aortic lymphadenopathy and splenunculus at the tail of the pancreas. Histological examination showed Hodgkin's disease in the lymph nodes and the splenunculus; the kidney presented acute tubular necrosis with extensive haemoglobin cast formation in distal tubular and collecting ducts.
Four ml of heparinised/EDTA blood sent to the Agriculture Research Institute at Compton, Berks, was inoculated, intravenously and subcutaneously, into a splenectomised bovine and produced a Babesia divergens parasitaemia at its maximum (9/1000 infected cells) seven days later. The parasite was also succcessfully isolated in gerbils (Meriones unguiculatus). Subsequent serological tests carried out at the Central Veterinary Laboratory at Weybridge, Surrey, confirmed that the parasite was B divergens.'
Comment
The patient who has had a splenectomy appears to have lost his most effective protection against these parasites:' and now that splenectomy is commonly performed a considerable number of people must at times be at risk-for example, on outdoor holidays. In blood films it is easy to confuse babesia with malaria parasites, and antimalarial treatment has been used in several of the cases recorded. A trial of diminazene and pentamidine, which are effective in animals,4 would appear to merit consideration in severe cases of human babesiosis. The extent to which B divergens may give rise to subclinical infections is unknown but the possibility may be worth considering in patients with fever where exposure to ticks has, or could have occurred. 
